Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingqing Cai

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
The Lancet. Haematology|September 17, 2025
Advancing understanding of mature T-cell and natural killer-cell lymphomasShunan Qi, Qingqing Cai
Translational Oncology|January 8, 2019
Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentQingqing Cai, Yu Fang, Ken H Young
Experimental & Molecular Medicine|January 24, 2015
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disordersQingqing Cai, Kailin Chen, Ken H Young
Blood Science (Baltimore, Md.)|December 15, 2022
Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphomaQihua Zou, Shuyun Ma, Xiaopeng Tian, et al.
Gene|September 12, 2018
MiR-875 and miR-3144 switch the human papillomavirus 16 E6/E6* mRNA ratio through the EGFR pathway and a direct targeting effectYanyun Li, Qingqing Cai, Lin Lin, et al.
Frontiers in Oncology|May 30, 2019
Epstein-Barr Virus-Positive Natural Killer/T-Cell LymphomaQingqing Cai, Jun Cai, Yu Fang, et al.
Frontiers in Microbiology|May 9, 2025
Genome assembly of <i>Klebsiella michiganensis</i> based on metagenomic next-generation sequencing reveals its genomic characteristics in population genetics and molecular epidemiologyYong Sun, Qingqing Cai, Tianyu Li, et al.
Oncotarget|September 30, 2015
MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementQingqing Cai, L Jeffrey Medeiros, Xiaolu Xu, et al.
Cardiology Plus|January 1, 2026
Association between immune checkpoint inhibitors and adverse cardiovascular events in patients with coronary artery disease and malignant tumors: a retrospective cohort studyRan Xu, Yan Wang, Qingqing Cai, et al.
Journal of Pharmaceutical Analysis|May 16, 2022
Reversible regulation of enzyme-like activity of molybdenum disulfide quantum dots for colorimetric pharmaceutical analysisJuan Tan, Shiyue Wu, Qingqing Cai, et al.
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
The Lancet. Haematology|September 17, 2025
Advancing understanding of mature T-cell and natural killer-cell lymphomasShunan Qi, Qingqing Cai
Translational Oncology|January 8, 2019
Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentQingqing Cai, Yu Fang, Ken H Young
Experimental & Molecular Medicine|January 24, 2015
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disordersQingqing Cai, Kailin Chen, Ken H Young
Blood Science (Baltimore, Md.)|December 15, 2022
Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphomaQihua Zou, Shuyun Ma, Xiaopeng Tian, et al.
Gene|September 12, 2018
MiR-875 and miR-3144 switch the human papillomavirus 16 E6/E6* mRNA ratio through the EGFR pathway and a direct targeting effectYanyun Li, Qingqing Cai, Lin Lin, et al.
Frontiers in Oncology|May 30, 2019
Epstein-Barr Virus-Positive Natural Killer/T-Cell LymphomaQingqing Cai, Jun Cai, Yu Fang, et al.
Frontiers in Microbiology|May 9, 2025
Genome assembly of <i>Klebsiella michiganensis</i> based on metagenomic next-generation sequencing reveals its genomic characteristics in population genetics and molecular epidemiologyYong Sun, Qingqing Cai, Tianyu Li, et al.
Oncotarget|September 30, 2015
MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementQingqing Cai, L Jeffrey Medeiros, Xiaolu Xu, et al.
Cardiology Plus|January 1, 2026
Association between immune checkpoint inhibitors and adverse cardiovascular events in patients with coronary artery disease and malignant tumors: a retrospective cohort studyRan Xu, Yan Wang, Qingqing Cai, et al.
Journal of Pharmaceutical Analysis|May 16, 2022
Reversible regulation of enzyme-like activity of molybdenum disulfide quantum dots for colorimetric pharmaceutical analysisJuan Tan, Shiyue Wu, Qingqing Cai, et al.
Pageof 23